Hôpital Maisonneuve-Rosemont

Montreal, Quebec H1T2M4

3 studies enrolling now · 34 studies all time

What they study most

ARDS, Acute Coronary Syndrome, Alzheimer's Disease, Antibiotic-associated Diarrhea, Aspergillosis, C-Difficile, COVID-19, Candidemia, Candidiasis, Invasive, Carcinoma, Non-Squamous Non-Small Cell Lung, Covid-19, Crohn Disease

Studies at this site

• A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease — Recruiting now
• Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) — Recruiting now
• Proximal FEmur Reconstruction or Internal Fixation fOR Metastases (PERFORM) Trial — Recruiting now
• Adoptive Cell Therapy Long-term Follow-up (LTFU) Study — Recruiting now
• A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema — Completed
• Optimization of Prostate Biopsy - Micro-Ultrasound Versus MRI — Completed
• A Long-term Follow-up Study of Patients Who Received VOR33 — Stopped early
• Allogeneic Engineered Hematopoietic Stem Cell Transplant (HCT) Lacking the CD33 Protein, and Post-HCT Treatment With Mylotarg, for Patients With CD33+ AML or MDS — Stopped early
• An Open-Label Phase 2 Trial of Nanatinostat Plus Valganciclovir in Patients With EBV+ Relapsed/Refractory Lymphomas — Stopped early
• A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema — Completed
• AB-16B5 Combined With Docetaxel in Subjects With Metastatic Non-Small Cell Lung Cancer (EGIA-002) — Completed
• Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi — Completed
• Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections — Completed
• Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 — Stopped early
• Surveillance AFter Extremity Tumor surgerY — Running, not enrolling
• A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC Vs. Placebo + SOC in Adult Hospitalized Patients with COVID-19 — Paused
• Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies — Stopped early
• Re-EValuating the Inhibition of Stress Erosions (REVISE) Trial — Completed
• Pharmacokinetic Guided Dose Escalation and Dose Confirmation With Oral Decitabine and Oral Cytidine Deaminase Inhibitor (CDAi) in Patients With Myelodysplastic Syndromes (MDS) — Completed
• mRNA-2736 for Participants With Relapsed or Refractory Multiple Myeloma (RRMM) — Withdrawn before enrolling
• A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease — Completed
• CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients — Stopped early
• CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1) — Stopped early
• A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors — Completed
• A Study of Atezolizumab in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin+Nab-Paclitaxel in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) — Completed
• LEADERS FREE II: BioFreedom™ Pivotal Study — Running, not enrolling
• Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial — Completed
• Efficacy and Safety Study of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis — Stopped early
• A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration — Stopped early
• A Trial of ASP7487 (OSI-906) in Combination With Bortezomib for the Treatment of Relapsed Multiple Myeloma — Stopped early
• The SOX Trial: Compression Stockings to Prevent the Post-Thrombotic Syndrome — Completed
• A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease — Stopped early
• Biomarker Sub Study of the Compression Stockings to Prevent the Post-Thrombotic Syndrome (SOX) Trial — Completed
• To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies — Completed